(Q36470465)

14 August 2017

1 reference

title

Update in diffuse parenchymal lung diseases 2005. (English)

1 reference

14 August 2017

1 reference

Fernando J Martinez

1

1 reference

PubMed ID

16679445

14 August 2017

Michael P Keane

series ordinal

2

1 reference

PubMed ID

16679445

14 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

American Journal of Respiratory and Critical Care Medicine

14 August 2017

1 reference

14 August 2017

173

1 reference

14 August 2017

10

1 reference

14 August 2017

1066-1071

1 reference

Clinical advances in the diagnosis and therapy of the interstitial lung diseases

14 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Idiopathic interstitial pneumonias: CT features

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Radiological versus histological diagnosis in UIP and NSIP: survival implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Do high-resolution CT findings of usual interstitial pneumonitis obviate lung biopsy? Views of pulmonologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Inter-observer variation between pathologists in diffuse parenchymal lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Clinical and pathologic features of familial interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Familial idiopathic pulmonary fibrosis: clinical features and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

The clinical course of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Antioxidant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Anticoagulant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Bone mineral density in lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Needs and opportunities for research in hypersensitivity pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Activation of discoidin domain receptor 1 on CD14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Attenuation of bleomycin-induced pulmonary fibrosis by follistatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Bone marrow-derived mesenchymal stem cells in repair of the injured lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

ABCA3 gene mutations in newborns with fatal surfactant deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

ABCA3 mutations associated with pediatric interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Endotoxin up-regulates interleukin-18: potential role for gram-negative colonization in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Study of C-C Chemokine Receptor 2 Alleles in Sarcoidosis, with Emphasis on Family-based Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Histopathologic Features and Outcome of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis Undergoing Surgical Lung Biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Characterization of fibroblast-specific protein 1 in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2601011

21 January 2018

Identifiers

DOI

10.1164/RCCM.2601011

1 reference

14 August 2017

1 reference

PubMed ID

16679445